![June McLenaghan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
June McLenaghan
Keine laufenden Positionen mehr
Profil
June McLenaghan worked as an Operations Director at Xceleron Ltd.
from 2003 to 2013.
She also worked as a Senior Analyst at K.S.
Biomedix Holdings Plc and Unipath Ltd.
Ms. McLenaghan obtained an undergraduate degree from The University of Stirling.
Ehemalige bekannte Positionen von June McLenaghan
Unternehmen | Position | Ende |
---|---|---|
Xceleron Ltd.
![]() Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Geschäftsführer | 24.01.2013 |
K.S. Biomedix Holdings Plc | Corporate Officer/Principal | - |
Unipath Ltd.
![]() Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million. | Corporate Officer/Principal | - |
Ausbildung von June McLenaghan
The University of Stirling | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Xceleron Ltd.
![]() Xceleron Ltd. Miscellaneous Commercial ServicesCommercial Services Xceleron Ltd. provides bioanalytical Accelerator Mass Spectrometry (AMS) services for accelerated early drug development. The company uses ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It was founded in 1997 and is located in York, the United Kingdom. | Commercial Services |
Unipath Ltd.
![]() Unipath Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million. | Health Technology |
K.S. Biomedix Holdings Plc | Health Technology |